Skip to main content
. 2012 Jan 12;3(4):787–790. doi: 10.3892/ol.2012.566

Figure 1.

Figure 1

Association between FN1 expression and clinical outcome in all patients (Kaplan-Meier; n=153 evaluable): The tumor-specific survival of patients with FN1 expression was significantly shorter; 5-year tumor-specific survival rates were calculated at 64.8 and 77.7% (p=0.035, Mantel-Cox).